Generex social media post today: BioSpace has
Post# of 36501
![](/assets/46931549/no_avatar_available_thumb.jpg)
BioSpace has listed the FDA approval of Trodelvy for TNBC as one of the biggest new drug approvals in 2020. NuGenerex Immuno-Oncology hopes to soon join the fight against TNBC with its Ii-key HER2/neu (AE37) vaccine not just to target the cancer with an antibody and payload, but to generate memory immunity against it.
#tnbc #coronavirusvaccine #sarscov2 #immunology #immunotherapy #tcells #biotechnology #clinicaltrial #Iikeypeptide
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)